Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Wilson

Showing results (221-230 of 261) with videos related to

Pageof 27
Sort By:
The Lancet. Gastroenterology & Hepatology|December 20, 2017
Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D): a phase 2-3 randomised trialRichard Adams, Ewan Brown, Louise Brown, et al.
Frontiers in Immunology|June 9, 2018
Cleavage-Independent HIV-1 Trimers From CHO Cell Lines Elicit Robust Autologous Tier 2 Neutralizing AntibodiesShridhar Bale, Alexandra Martiné, Richard Wilson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Phase I study of the poly(ADP-ribose) polymerase inhibitor, AG014699, in combination with temozolomide in patients with advanced solid tumorsRuth Plummer, Christopher Jones, Mark Middleton, et al.
Health Technology Assessment (Winchester, England)|March 21, 2024
Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis: the EASI-SWITCH RCTVicky Coyle, Caroline Forde, Richard Adams, et al.
Plos One|September 13, 2012
Identification and characterization of a broadly cross-reactive HIV-1 human monoclonal antibody that binds to both gp120 and gp41Mei-Yun Zhang, Tingting Yuan, Jingjing Li, et al.
American Journal of Epidemiology|May 13, 2017
Acute Illness Among Surfers After Exposure to Seawater in Dry- and Wet-Weather ConditionsBenjamin F Arnold, Kenneth C Schiff, Ayse Ercumen, et al.
Plos Genetics|October 17, 2009
Targeted induction of endoplasmic reticulum stress induces cartilage pathologyM Helen Rajpar, Ben McDermott, Louise Kung, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2014
Vaccine-elicited primate antibodies use a distinct approach to the HIV-1 primary receptor binding site informing vaccine redesignKaren Tran, Christian Poulsen, Javier Guenaga, et al.
The EMBO Journal|November 3, 2025
Tyrosine kinase targeting uncovers oncogenic pathway plasticity in Tasmanian devil transmissible cancersAnna Schönbichler, Anna Orlova, Carmen Kreindl, et al.
Journal of Virology|August 25, 2017
HIV-1 Cross-Reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Nonhuman PrimatesYimeng Wang, Sijy O'Dell, Hannah L Turner, et al.
Pageof 27

Showing results (221-230 of 261) with videos related to

Sort By:
Pageof 27
The Lancet. Gastroenterology & Hepatology|December 20, 2017
Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D): a phase 2-3 randomised trialRichard Adams, Ewan Brown, Louise Brown, et al.
Frontiers in Immunology|June 9, 2018
Cleavage-Independent HIV-1 Trimers From CHO Cell Lines Elicit Robust Autologous Tier 2 Neutralizing AntibodiesShridhar Bale, Alexandra Martiné, Richard Wilson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Phase I study of the poly(ADP-ribose) polymerase inhibitor, AG014699, in combination with temozolomide in patients with advanced solid tumorsRuth Plummer, Christopher Jones, Mark Middleton, et al.
Health Technology Assessment (Winchester, England)|March 21, 2024
Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis: the EASI-SWITCH RCTVicky Coyle, Caroline Forde, Richard Adams, et al.
Plos One|September 13, 2012
Identification and characterization of a broadly cross-reactive HIV-1 human monoclonal antibody that binds to both gp120 and gp41Mei-Yun Zhang, Tingting Yuan, Jingjing Li, et al.
American Journal of Epidemiology|May 13, 2017
Acute Illness Among Surfers After Exposure to Seawater in Dry- and Wet-Weather ConditionsBenjamin F Arnold, Kenneth C Schiff, Ayse Ercumen, et al.
Plos Genetics|October 17, 2009
Targeted induction of endoplasmic reticulum stress induces cartilage pathologyM Helen Rajpar, Ben McDermott, Louise Kung, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2014
Vaccine-elicited primate antibodies use a distinct approach to the HIV-1 primary receptor binding site informing vaccine redesignKaren Tran, Christian Poulsen, Javier Guenaga, et al.
The EMBO Journal|November 3, 2025
Tyrosine kinase targeting uncovers oncogenic pathway plasticity in Tasmanian devil transmissible cancersAnna Schönbichler, Anna Orlova, Carmen Kreindl, et al.
Journal of Virology|August 25, 2017
HIV-1 Cross-Reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Nonhuman PrimatesYimeng Wang, Sijy O'Dell, Hannah L Turner, et al.
Pageof 27